Infectious Disease Clinics of North America volume 25, issue 4, P865-893 2011 DOI: 10.1016/j.idc.2011.07.010 View full text
|
|
Share
Vidya Sundareshan, Jignesh Modi, Nancy Misri Khardori

Abstract: With increasing use of biological response modifiers (BRMs) for various systemic inflammatory diseases there is a need to be vigilant about complications with the use of these therapies. It is important to have appropriate screening for the infections in patients requiring BRMs. However, many studies have reported benefits of certain BRMs in the treatment of infections such as tuberculosis as adjuncts. Continued research and technical advances in immunogenetics helps understand complex mechanisms in the usage …

expand abstract